Gagnon Advisors, LLC Chembio Diagnostics, Inc. Transaction History

Gagnon Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$2.36 - $5.6 $587,833 - $1.39 Million	-249,082 Closed	0 $0
Q4 2018 Jan 18, 2019	BUY	$4.95 - $10.5 $269,789 - $572,281	54,503 Added 28.01%	249,082 $1.41 Million
Q2 2018 Aug 09, 2018	BUY	$7.8 - $11.1 $507,046 - $721,566	65,006 Added 50.17%	194,579 $2.16 Million
Q1 2018 May 09, 2018	BUY	$7.05 - $9.0 $913,489 - $1.17 Million	129,573 New	129,573 $1.04 Million

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Gagnon Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Gagnon Advisors, LLC with notifications on news.